IXJ Among Health Care ETFs
End-of-day Nov 20, 2026 · 27 Health care ETFs by 5Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.5% | −5.8% | −2.0% | +1.2% | +12.0% | +14.8% | +38.5% | +32.6% | +154.4% | +443.4% |
| Peer average | −1.3% | −6.4% | −4.5% | −5.9% | +13.4% | +17.5% | +58.2% | +19.5% | +146.1% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$115 of every $1,000 in IXJ is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYELI Lilly | Healthcare | 11.49% | $1,149.49 | 383K | $517.4M |
| 2 | JNJJohnson & Johnson | Healthcare | 6.84% | $684.48 | 1.2M | $308.1M |
| 3 | ABBVAbbvie | Healthcare | 5.33% | $532.72 | 846K | $239.8M |
| 4 | ROP.SWRoche PS PAR AG | Healthcare | 3.89% | $388.99 | 370K | $175.1M |
| 5 | MRKMerck | Healthcare | 3.83% | $382.53 | 1.3M | $172.2M |
| 6 | UNHUnitedhealth Group | Healthcare | 3.47% | $346.82 | 472K | $156.1M |
| 7 | NOVN.SWNovartis AG | Healthcare | 3.23% | $323.19 | 964K | $145.5M |
| 8 | AZN.LAstrazeneca | Healthcare | 3.16% | $316.49 | 816K | $142.5M |
| 9 | TMOThermo Fisher Scientific | Healthcare | 2.98% | $297.75 | 195K | $134.0M |
| 10 | AMGNAmgen | Healthcare | 2.77% | $277.37 | 285K | $124.9M |
| 11 | GILDGilead Sciences | Healthcare | 2.41% | $241.49 | 653K | $108.7M |
| 12 | ABTAbbott Laboratories | Healthcare | 2.10% | $210.14 | 911K | $94.6M |
| 13 | PFEPfizer | Healthcare | 1.84% | $183.52 | 3.0M | $82.6M |
| 14 | ISRGIntuitive Surgical | Healthcare | 1.68% | $168.30 | 186K | $75.8M |
| 15 | DHRDanaher | Healthcare | 1.66% | $166.46 | 329K | $74.9M |
of the $108B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly | 11.49% |
| 2 | JNJ | Johnson & Johnson | 6.84% |
| 3 | ABBV | Abbvie | 5.33% |
| 4 | ROP.SW | Roche PS PAR AG | 3.89% |
| 5 | MRK | Merck & | 3.83% |
| 6 | UNH | Unitedhealth Group | 3.47% |
| 7 | NOVN.SW | Novartis AG | 3.23% |
| 8 | AZN.L | Astrazeneca | 3.16% |
| 9 | TMO | Thermo Fisher Scientific | 2.98% |
| 10 | AMGN | Amgen | 2.77% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Jun 15, 2026 | Jun 18, 2026 | $0.85 |
| Dec 16, 2025 | Dec 19, 2025 | $0.60 |
| Jun 16, 2025 | Jun 20, 2025 | $0.76 |
| Dec 17, 2024 | Dec 20, 2024 | $0.62 |
| Jun 11, 2024 | Jun 17, 2024 | $0.67 |
| Dec 20, 2023 | Dec 27, 2023 | $0.56 |
| Jun 7, 2023 | Jun 13, 2023 | $0.64 |
| Dec 13, 2022 | Dec 19, 2022 | $0.44 |
| Jun 9, 2022 | Jun 15, 2022 | $0.55 |
| Dec 13, 2021 | Dec 17, 2021 | $0.48 |
| Jun 10, 2021 | Jun 16, 2021 | $0.53 |
| Dec 14, 2020 | Dec 18, 2020 | $0.44 |